FDA Inspection 810165 — Metropolitan Reproductive Medicine, P.C.

Metropolitan Reproductive Medicine, P.C. — FEI 3006721953

The FDA completed an inspection of Metropolitan Reproductive Medicine, P.C. on December 14, 2012 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 14, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures